The rising prevalence in GLP-1 drugs for diabetes has led to a debate about formats: skin-applied devices versus tablets . Typically, GLP-1 treatments were only available in tablet form, but the development of transdermal delivery provides a new option . Transdermal systems might suit individuals experiencing challenges swallowing tablets , thos… Read More